ALVO
Price
$10.66
Change
+$0.16 (+1.52%)
Updated
Jun 6 closing price
Capitalization
3.48B
67 days until earnings call
EBS
Price
$6.63
Change
+$0.58 (+9.59%)
Updated
Jun 6 closing price
Capitalization
120.07M
66 days until earnings call
Interact to see
Advertisement

ALVO vs EBS

Header iconALVO vs EBS Comparison
Open Charts ALVO vs EBSBanner chart's image
Alvotech
Price$10.66
Change+$0.16 (+1.52%)
Volume$173.76K
Capitalization3.48B
Emergent Biosolutions
Price$6.63
Change+$0.58 (+9.59%)
Volume$915.57K
Capitalization120.07M
ALVO vs EBS Comparison Chart
Loading...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALVO vs. EBS commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and EBS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ALVO: $10.66 vs. EBS: $6.63)
Brand notoriety: ALVO and EBS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALVO: 82% vs. EBS: 77%
Market capitalization -- ALVO: $3.48B vs. EBS: $120.07M
ALVO [@Pharmaceuticals: Other] is valued at $3.48B. EBS’s [@Pharmaceuticals: Other] market capitalization is $120.07M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 0 FA rating(s) are green whileEBS’s FA Score has 1 green FA rating(s).

  • ALVO’s FA Score: 0 green, 5 red.
  • EBS’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALVO and EBS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 5 TA indicator(s) are bullish while EBS’s TA Score has 6 bullish TA indicator(s).

  • ALVO’s TA Score: 5 bullish, 5 bearish.
  • EBS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, EBS is a better buy in the short-term than ALVO.

Price Growth

ALVO (@Pharmaceuticals: Other) experienced а -6.82% price change this week, while EBS (@Pharmaceuticals: Other) price change was +4.91% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +78.59%. For the same industry, the average monthly price growth was +15.33%, and the average quarterly price growth was +66.92%.

Reported Earning Dates

ALVO is expected to report earnings on Aug 13, 2025.

EBS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+78.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($3.48B) has a higher market cap than EBS($120M). ALVO has higher P/E ratio than EBS: ALVO (57.47) vs EBS (17.73). ALVO YTD gains are higher at: -19.426 vs. EBS (-30.649). ALVO (-493.67M) and EBS (-518.2M) have comparable annual earnings (EBITDA) . EBS has more cash in the bank: 112M vs. ALVO (11.2M). EBS has less debt than ALVO: EBS (860M) vs ALVO (1.08B). EBS has higher revenues than ALVO: EBS (1.02B) vs ALVO (91.4M).
ALVOEBSALVO / EBS
Capitalization3.48B120M2,896%
EBITDA-493.67M-518.2M95%
Gain YTD-19.426-30.64963%
P/E Ratio57.4717.73324%
Revenue91.4M1.02B9%
Total Cash11.2M112M10%
Total Debt1.08B860M125%
FUNDAMENTALS RATINGS
EBS: Fundamental Ratings
EBS
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALVOEBS
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 11 days ago
63%
Bullish Trend 18 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANGPY7.080.24
+3.51%
Valterra Platinum Ltd
SAFRY75.890.45
+0.60%
Safran SA
MMNGF0.21N/A
+0.35%
Metallic Minerals Corp.
WTKWY177.48-1.88
-1.05%
Wolters Kluwer N.V.
WRDLY2.84-0.11
-3.73%
Worldline SA

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+1.52%
EBS - ALVO
26%
Poorly correlated
+9.59%
PBH - ALVO
24%
Poorly correlated
+0.52%
PAHC - ALVO
24%
Poorly correlated
+0.80%
AKAN - ALVO
24%
Poorly correlated
+7.09%
KMDA - ALVO
24%
Poorly correlated
+1.03%
More

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with HROW. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then HROW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
+9.59%
HROW - EBS
37%
Loosely correlated
+3.03%
AMRX - EBS
36%
Loosely correlated
+6.28%
SIGA - EBS
32%
Poorly correlated
+2.55%
VTRS - EBS
29%
Poorly correlated
+2.96%
ZOMDF - EBS
29%
Poorly correlated
-2.09%
More